Applied Therapeutics (APLT) Operating Income (2023 - 2025)
Historic Operating Income for Applied Therapeutics (APLT) over the last 3 years, with Q3 2025 value amounting to -$16.8 million.
- Applied Therapeutics' Operating Income rose 4365.73% to -$16.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$98.4 million, marking a year-over-year decrease of 663.06%. This contributed to the annual value of -$104.3 million for FY2024, which is 6161.62% down from last year.
- According to the latest figures from Q3 2025, Applied Therapeutics' Operating Income is -$16.8 million, which was up 4365.73% from -$23.1 million recorded in Q2 2025.
- In the past 5 years, Applied Therapeutics' Operating Income registered a high of -$10.9 million during Q1 2023, and its lowest value of -$33.0 million during Q4 2024.
- Moreover, its 3-year median value for Operating Income was -$21.0 million (2023), whereas its average is -$21.3 million.
- Per our database at Business Quant, Applied Therapeutics' Operating Income plummeted by 9426.23% in 2024 and then soared by 4365.73% in 2025.
- Quarter analysis of 3 years shows Applied Therapeutics' Operating Income stood at -$21.0 million in 2023, then crashed by 57.19% to -$33.0 million in 2024, then skyrocketed by 49.25% to -$16.8 million in 2025.
- Its last three reported values are -$16.8 million in Q3 2025, -$23.1 million for Q2 2025, and -$25.5 million during Q1 2025.